Woodmont Investment Counsel LLC grew its holdings in National Health Investors, Inc. (NYSE:NHI) by 1.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,414 shares of the real estate investment trust’s stock after buying an additional 45 shares during the period. Woodmont Investment Counsel LLC’s holdings in National Health Investors were worth $270,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in NHI. BlackRock Inc. lifted its position in shares of National Health Investors by 6,473.4% in the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after buying an additional 3,277,930 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of National Health Investors by 3.3% in the first quarter. Vanguard Group Inc. now owns 6,219,436 shares of the real estate investment trust’s stock valued at $451,717,000 after buying an additional 201,133 shares during the last quarter. Nuveen Asset Management LLC acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $11,559,000. MARSHALL WACE ASIA Ltd acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $6,794,000. Finally, Marshall Wace North America L.P. acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $6,794,000. 70.67% of the stock is owned by institutional investors.

A number of analysts have recently issued reports on the company. BidaskClub cut National Health Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Zacks Investment Research cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, September 6th. Stifel Nicolaus raised their price objective on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Finally, KeyCorp reaffirmed a “hold” rating on shares of National Health Investors in a research report on Sunday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. National Health Investors has an average rating of “Hold” and a consensus price target of $80.50.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now owns 21,228 shares in the company, valued at $1,693,994.40. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 5.19% of the stock is currently owned by corporate insiders.

Shares of National Health Investors, Inc. (NHI) traded up 0.49% during trading on Thursday, hitting $79.95. The stock had a trading volume of 29,022 shares. National Health Investors, Inc. has a 52 week low of $66.31 and a 52 week high of $81.29. The company has a market capitalization of $3.28 billion, a price-to-earnings ratio of 20.53 and a beta of 0.56. The company’s 50 day moving average price is $78.73 and its 200 day moving average price is $76.04.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the consensus estimate of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The firm had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same quarter in the previous year, the company posted $1.22 EPS. National Health Investors’s revenue for the quarter was up 14.1% on a year-over-year basis. Analysts predict that National Health Investors, Inc. will post $3.85 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be paid a $0.95 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.80 annualized dividend and a yield of 4.78%. National Health Investors’s payout ratio is 97.69%.

COPYRIGHT VIOLATION NOTICE: “National Health Investors, Inc. (NHI) Stake Increased by Woodmont Investment Counsel LLC” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/national-health-investors-inc-nhi-stake-increased-by-woodmont-investment-counsel-llc/1578315.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.